Media Coverage
13 April 2023
BioCentury Article: Cell and gene therapy must prioritize simplification, standardization before focusing on automation
Josh Ludwig, Global Director of Commercial Operations at ScaleReady, reviews how the industry is addressing the challenges that come with...9 February 2023
For the Record - Medical Alley Interview with Josh Ludwig
Medical Alley
7 October 2021
CancerNetworks Interviews ScaleReady
Josh Ludgwig, Global Director of Commercial Operations at ScaleReady discusses what makes the company uniquely positioned to support manufacturing across...1 October 2021
ScaleReady Joins the Alliance for Regenerative Medicine
As a member of The Alliance for Regenerative Medicine (ARM), ScaleReady committed to progressing regenerative medicine and advanced therapy manufacturing...25 May 2021